Skip to main content
. 2020 Sep 21;27(12):1665–1678. doi: 10.1016/j.acra.2020.09.004

Table 2.

Clinical Outcomes in Terms of Disease Severity and Prognosis

Disease Severity Moderate Severe Critical
Hospitalization (days) 14.60 ± 7.57 (Median: 12) 18.11 ± 8.20 (Median: 16) 33.26 ± 17.38 (Median: 28)
ICU length (days) 0.24 ± 1.20 (Median: 0) (1pt) 1.34 ± 5.72 (Median: 0) (6pt) 25.07 ± 23.64 (Median: 12) (25pt)
Oxygen inhalation (days) 13.08 ± 8.10 (Median: 10) 16.64 ± 8.03 (Median: 15) 32.93 ± 17.62 (Median: 28)
Sputum NAT-positive (days) 9.56 ± 7.56 (Median: 8) 10.89 ± 7.88 (Median: 9) 13.70 ± 6.60 (Median: 13)
Prognosis (category) 1.92 ± 0.28 (Median: 2) 2.00 ± 0.21 (Median: 2) 2.59 ± 0.57 (Median: 3)
(Prognosis, Complete Recovery, Partial Recovery, Prolonged Recovery)
Hospitalization (days) 14.7 ± 2.3 (Median: 16) 16.7 ± 7.3 (Median: 15) 46.6 ± 12.1 (Median: 50)
ICU length (days) 0.0 ± 0.0 (Median: 0) 1.0 ± 2.3 (Median: 0) 42.3 ± 18.6 (Median:49)
Oxygen inhalation (days) 13.7 ± 2.5 (Median: 14) 15.4 ± 7.3 (Median: 15) 46.4 ± 12.4 (Median: 50)
Sputum NAT-positive (days) 8.7 ± 3.2 (Median: 10) 10.4 ± 7.6 (Median: 8) 15.8 ± 4.6 (Median: 17)

As per disease severity, 99 patients were categorized into three groups: moderate (n = 25), severe (n = 47), and critical (n = 27), respectively. As per prognosis, patients were categorized into 1: complete recovery (n = 3), 2: partial recovery with residual pulmonary damage (n = 80), 3: prolonged recovery (n = 15), and 4: death (n = 1).